Molecular profiling of tumours by immunohistochemistry.
Sarkar
Chitra
C
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D007150:Immunohistochemistry; D009154:Mutation; D009369:Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D010879:Piperazines; D019009:Proto-Oncogene Proteins c-kit; D011743:Pyrimidines; D000069283:Rituximab; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D016159:Tumor Suppressor Protein p53; D000069283:Rituximab; D000068877:Imatinib Mesylate; D019009:Proto-Oncogene Proteins c-kit